MeSH terms

• Antineoplastic Agents / pharmacology*
• Biomarkers, Tumor / metabolism*
• Clinical Trials, Phase II as Topic* / methods
• Clinical Trials, Phase II as Topic* / standards
• Clinical Trials, Phase III as Topic / methods
• Clinical Trials, Phase III as Topic / standards
• Confounding Factors, Epidemiologic
• Disease-Free Survival
• Humans
• Neoplasms / drug therapy*
• Neoplasms / metabolism*
• Observer Variation
• Predictive Value of Tests
• Prognosis
• Randomized Controlled Trials as Topic* / methods
• Randomized Controlled Trials as Topic* / standards
• Research Design
• Risk Factors
• Survival Analysis
• Treatment Failure
• Treatment Outcome